Literature DB >> 1940975

Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders.

M Weller1, A Stevens, N Sommer, A Melms, J Dichgans, H Wiethölter.   

Abstract

Interleukins (IL) 1, 2, 4, 6 and soluble IL-2 receptor (sIL-2R), interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha) were measured in CSF and serum from patients with relapsing-remitting and chronic multiple sclerosis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, HIV infection, bacterial meningitis, viral encephalitis, meningeal carcinomatosis, hematologic meningeal malignancies, and disseminated melanoma. Our findings suggest that monitoring of disease activity in neuroimmunologic disorders by means of IL-1 beta, IL-2, sIL-2R, or IL-4 determination will not prove useful. IL-6, on the other hand, indicates relapse in multiple sclerosis and active disease in Guillain-Barré syndrome and meningeal carcinomatosis. High CSF TNF-alpha in metastatic melanoma and frequent detection in CSF of the multifunctional B-cell growth factor, IL-6 (27/30) and oligoclonal immunoglobulin bands (33%) in meningeal carcinomatosis confirm an intrathecal immune response in disseminated leptomeningeal neoplasia which might be amenable to therapeutic immunomodulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940975     DOI: 10.1016/0022-510x(91)90313-v

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.

Authors:  M Dettke; P Scheidt; H Prange; H Kirchner
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

2.  Bickerstaff brainstem encephalitis after heat stroke.

Authors:  Akiyuki Uzawa; Masahiro Mori; Noriko Tamura; Hirokatsu Takahashi; Hiroyuki Hirasawa; Takamichi Hattori; Satoshi Kuwabara
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

3.  Local effects of recombinant rat interleukin-6 on the peripheral nervous system.

Authors:  G Deretzi; S H Pelidou; L P Zou; C Quiding; J Zhu
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

4.  The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.

Authors:  Meng-Ya Si; Zhi-Cheng Fan; Ya-Zhen Li; Xiao-Lan Chang; Qing-Dong Xie; Xiao-Yang Jiao
Journal:  J Neurooncol       Date:  2015-01-30       Impact factor: 4.130

5.  Modeling toxicodynamic effects of trichloroethylene on liver in mouse model of autoimmune hepatitis.

Authors:  Kathleen M Gilbert; Brad Reisfeld; Todd J Zurlinden; Meagan N Kreps; Stephen W Erickson; Sarah J Blossom
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-12       Impact factor: 4.219

Review 6.  Viral and inflammatory triggers of neurodegenerative diseases.

Authors:  Michela Deleidi; Ole Isacson
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

7.  The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.

Authors:  Michela Deleidi; Penelope J Hallett; James B Koprich; Chee-Yeun Chung; Ole Isacson
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

8.  Rit signaling contributes to interferon-gamma-induced dendritic retraction via p38 mitogen-activated protein kinase activation.

Authors:  Douglas A Andres; Geng-Xian Shi; Donald Bruun; Chris Barnhart; Pamela J Lein
Journal:  J Neurochem       Date:  2008-10-24       Impact factor: 5.372

9.  The acute paralysis in Guillain-Barré syndrome is related to a Na+ channel blocking factor in the cerebrospinal fluid.

Authors:  H Brinkmeier; K H Wollinsky; P J Hülser; M J Seewald; H H Mehrkens; H H Kornhuber; R Rüdel
Journal:  Pflugers Arch       Date:  1992-09       Impact factor: 3.657

10.  Cytokine mRNA profiles in mononuclear cells in acute aseptic meningoencephalitis.

Authors:  V Navikas; M Haglund; J Link; B He; L Lindqvist; S Fredrikson; H Link
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.